- Home
- SIGA vs ETO Comparison
SIGA vs ETO Comparison
Compare SIGA & ETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SIGA | ETO |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.0M | 471.2M |
| IPO Year | 2016 | 2004 |
Fundamental Metrics
Financial Performance| Metric | SIGA | ETO |
|---|---|---|
| Price | $5.17 | $27.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 751.2K | 38.1K |
| Earning Date | 03-10-2026 | 01-01-0001 |
| Dividend Yield | ★ 11.21% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $224.81 | N/A |
| P/E Ratio | $16.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.81 | $20.05 |
| 52 Week High | $9.62 | $31.11 |
Technical Indicators
Market Signals| Indicator | SIGA | ETO |
|---|---|---|
| Relative Strength Index (RSI) | 40.04 | 45.95 |
| Support Level | $4.81 | $26.84 |
| Resistance Level | $6.98 | $27.67 |
| Average True Range (ATR) | 0.23 | 0.65 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 50.00 | 64.50 |
Price Performance
Historical ComparisonAbout SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About ETO Eaton Vance Tax-Advantage Global Dividend Opp
Eaton Vance Tax-advtgd Global Divid Oppo is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. The portfolio of investments consists of capital markets, chemicals, diversified, beverages, banks, electric utilities, oil, gas and consumable fuels, personal products, and other areas.